This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
NOI to Sole Source to Central Admixture Services, Inc.
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health (NIH) intends to award a one-year, firm fixed price contract to Central Admixture Pharmacy Services, Inc. (CAPS, Inc.) for the supply of select non-patient-specific sterile compounded products, including patient-specific parenteral nutrition and renal replacement therapy, for use at the NIH Clinical Center in Bethesda, Maryland. CAPS, Inc., the original manufacturer of these compounded products, is the sole source for these items in the U.S., with no other designated distributors. The acquisition falls under the NAICS code 325412 for pharmaceutical preparation manufacturing and Product Service Code 6515 for medical and surgical instruments, equipment, and supplies. This acquisition is conducted under the Federal Acquisition Regulation (FAR) Part 13 Simplified Acquisition Procedures for purchases not exceeding the simplified acquisition threshold, allowing the contracting officer to award to a single source without competition when deemed appropriate. No solicitation or request for quotations will be issued for this procurement. Interested parties may submit comments regarding this sole source acquisition to the NIH Office of Purchasing and Contracts by May 26, 2026, 3 pm EST. The contract aims to ensure continuous provision of high-quality compounded sterile products for patient care at the NIH Clinical Center.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The purpose of this acquisition is to contract with a source for select non-patient-specific sterile compounded products and patient specific parenteral nutrition and renal replacement therapy that meet the quality expectations to provide to National Institutes of Health Clinical Center (NIH CC) patients on an ongoing basis.
• Product Service Code: 6515 – Medical and Surgical Instruments, Equipment, and Supplies
• NAICS Code: 325412 – Pharmaceutical Preparation Manufacturing
• Place of Performance: NIH Clinical Center, Bethesda, MD 20892 USA
POTS: 26-000037
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a one-year contract to Central Admixture Pharmacy Services, Inc. (CAPS, Inc.), located at PO. BOX 780404, Philadelphia, PA 19178, on a firm fixed price sole source award basis for the purchase of compounded TPN and other compounded products for patient care.
The proposed vendor, CAPS Inc., is the Original Manufacturer and has not designated other distributors for compounded products in the U.S.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Huda Malik, Contract Specialist via email to huda.malik@nih.gov by May 26, 2026 by 3 pm EST.